ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 249 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,710,380 | +26.9% | 90,881 | +7.3% | 0.19% | +26.8% |
| Q4 2022 | $1,347,867 | -26.6% | 84,665 | -24.6% | 0.15% | -23.5% |
| Q3 2022 | $1,836,000 | -38.8% | 112,239 | -47.3% | 0.20% | -32.4% |
| Q2 2022 | $3,002,000 | +460.1% | 213,094 | +863.4% | 0.30% | +410.3% |
| Q1 2022 | $536,000 | -75.6% | 22,118 | -83.3% | 0.06% | -65.5% |
| Q3 2021 | $2,196,000 | +747.9% | 132,205 | +1146.2% | 0.17% | +630.4% |
| Q2 2021 | $259,000 | -38.6% | 10,609 | -35.1% | 0.02% | -37.8% |
| Q1 2021 | $422,000 | -72.4% | 16,341 | -42.9% | 0.04% | -67.5% |
| Q4 2020 | $1,531,000 | – | 28,638 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |